购物车
- 全部删除
- 您的购物车当前为空
LY2090314 是GSK-3抑制剂,抑制 GSK-3α (IC50:1.5 nM) 和 GSK-3β (IC50:0.9 nM)。
为众多的药物研发团队赋能,
让新药发现更简单!
LY2090314 是GSK-3抑制剂,抑制 GSK-3α (IC50:1.5 nM) 和 GSK-3β (IC50:0.9 nM)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 389 | 现货 | |
2 mg | ¥ 562 | 现货 | |
5 mg | ¥ 889 | 现货 | |
10 mg | ¥ 1,420 | 现货 | |
25 mg | ¥ 2,560 | 现货 | |
50 mg | ¥ 3,890 | 现货 | |
100 mg | ¥ 5,560 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 987 | 现货 |
产品描述 | LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. |
靶点活性 | GSK-3β:0.9 nM, GSK-3α:1.5 nM |
体内活性 | LY2090314在实体瘤癌异种移植模型中提高了顺铂和卡铂的疗效。[1] |
分子量 | 512.53 |
分子式 | C28H25FN6O3 |
CAS No. | 603288-22-8 |
Smiles | Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1 |
密度 | 1.55 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 93 mg/mL (181.5 mM) Ethanol: 2 mg/mL (3.9 mM), Heating is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容